Paris, June 8, 2023.
GENEO Capital Entrepreneur posts record results in 2022 and strengthens its vocation as an impact investment company in 2023
Founded in 2019 by Fanny Letier and François Rivolier, GENEO Capital Entrepreneur currently manages over €600 million through three investment vehicles offering French companies, European leaders in their field, a wide range of financial products to support their growth over the long term.
GENEO Capital Entrepreneur is unique in that it offers its investments an integrated operational support program ("le Carnet de croissance"), a human resources platform dedicated to the companies invested in, concrete support for CSR and impact strategies (the "positive impact plan") and a unique Business Community.
Since its creation 4 years ago, GENEO Capital Entrepreneur has followed an investment trajectory in line with its ambition.
By December 31, 2022, the three investment vehicles were managing a total of over €600 million, divided between :
- GENEO Capital (an evergreen investment company dedicated to growth SMEs and ETIs).
- A Relance Bond fund co-managed with Turenne Capital.
- A GENEO Mezzanine fund (quasi-equity fund dedicated to ETi committed to impact).
The community continues to grow, and now includes more than 220 investors, including :
- 157 entrepreneur holding companies
- 45 single family offices
- 18 institutional investors
22 European or international champions supported in the portfolios, with a strong impact in terms of jobs, with over 400 direct jobs created by 2022.
A fiscal 2022 marked by solid results, sustained business momentum and growing investment capacity
At its Annual General Meeting, investment company GENEO Capital presented a 2022 financial year marked by a sharp acceleration in growth: €83.7 million has been invested in 2022, representing a 35% increase over 2021.
Among the highlights of 2022, GENEO Capital made 5 investments in mid-sized companies in several regions:
- Zurflüh-Feller, Europe's leading manufacturer of technical components for home openings and closures.
- Neftys Pharma, Europe's leading distributor of veterinary products.
- Safic-Alcan, world leader in the distribution of specialty chemicals.
- Groupe G.A.C, leader in innovation and performance consulting.
- I-Run, Europe's leading online retailer of running, trail, outdoor, fitness and athletic gear.
- Plus 1 reinvestment enabling Hoppen (e-health) to acquire Exolis.
GENEO Capital offers a Carnet de croissance to the companies in which it invests, in the form of support provided by 4 in-house Business Partners and the possible mobilization of nearly 70 different types of external expertise. In 2022, 340 new support initiatives were launched, focusing on strategy and governance, positive impact, digital and innovation.
For the companies we support, this growth track record has resulted in more than 20 acquisitions in 2022 by 9 portfolio companies. In all, GENEO Capital's 18 holdings have completed 41 acquisitions since its arrival, 22 of them international. These companies are present in 46 countries worldwide
In addition, in 2022, six companies, including Odigo and Xefi, were financed by the Obligation Relance program.
GENEO Mezzanine, a bond vehicle tailor-made for ETi's wishing to increase their impact, led 2 investments (Enygea and Scutum) equivalent to nearly €25 million.
Investments guided by the objective of generating local impact
GENEO Capital Entrepreneur supports growing SMEs and ETi in their long-term development projects, creating a positive social, environmental and societal impact. Our main objectives are to :
Contribute to local job creation. As a result, in 2022, portfolio companies :
- Created 420 jobs
- Acquired 800 additional jobs through acquisitions
- Now represent 10,300 FTEs (full-time equivalent)
Supporting decarbonization. 68% of the companies in which GENEO Capital Entrepreneur invests have defined and/or implemented measures to reduce their carbon footprint.
- Among them 53% of companies in portfolio in 2022 have calculated their Scope 1 2 3 carbon footprint.
- The remaining 47% have initiated́ work on the subject of decarbonization and/or are in the process of calculating their carbon footprint.
Redistributing part of the value created: since 2020, GENEO has supported the École de Production Automobile de Lens, which trains for careers in automotive maintenance, as well as the Émergents La Mosaïc association, which promotes equal opportunity and territorial cohesion on educational issues in urban and rural areas.
In 2023, GENEO Capital Entrepreneur will strengthen the impact-based approach it has pursued since its creation.
Highlights from the beginning of the year include:
Changeover to mission company status.
In line with its raison d'être "positive finance" and its four founding pillars, GENEO Capital Entrepreneur is pursuing its commitment by becoming a mission-driven company.
This natural outcome is based on the four founding pillars that have been GENEO's DNA since its creation:
- Bringing peace of mind through time management, to get through economic cycles and adapt to the needs of each company.
- Promote the activation and growth of human capital as a decisive lever for value creation by providing operational and human support as well as expertise.
- Supporting the growth of each company's positive impact and its transition to sustainable business models.
- Sharing the value created with all stakeholders, to give each generation the means to achieve its ambitions.
- Launch of the Human Impact Index, in partnership with Harmonie Mutuelle and Human&Work.
The creation of this index is based on strong convictions:
- Financial and human performance go hand in hand.
- Great entrepreneurial adventures are above all collective.
- Social impact must be at the heart of corporate thinking and innovation.
This index is structured around 6 strategic themes: employment, governance, health in the workplace, diversity, value sharing and commitment.
It's a simple, multi-sector tool that gives small and medium-sized enterprises (SMEs) an overview of their social and human impact, and possible areas for improvement. Results will be measured and analyzed once a year.
The aim is to rapidly extend the use of the Human Impact Index to other companies and partners. To this end, the evaluation grid will be made available to all those wishing to join the initiative and improve their collective performance.
Fanny LETIER and François RIVOLIER, founders of GENEO Capital Entrepreneur, say : "We are proud to have achieved another year of record results. This performance underlines the relevance and attractiveness of our "evergreen" investment model. Our commitments, shared by the entire GENEO community, in terms of impact, job creation, human capital and social commitment are the driving forces behind our roadmap, which we will continue to deploy within our invested companies. We are committed to "positivizing" the finance of today and tomorrow, by reconciling performance and meaning.
The main impact results report and the 2022 activity report are available in full.
* * *
About the management company GENEO Capital Entrepreneur
GENEO Capital Entrepreneur's raison d'être is to make positive finance available to the real economy.
Designed to unlock the value creation, job creation and impact potential of SMEs and mid-sized companies, GENEO Capital Entrepreneur has nearly €600 million at its disposal. It manages in particular:
- the "evergreen" investment company GENEO Capital, which has a 99-year lifespan and is majority-owned by families and entrepreneurs. GENEO thus provides tailor-made capital that adapts to the pace of each company and provides responsiveness and flexibility. Its resources increase regularly as GENEO and the companies it invests develop.
- The GENEO Mezzanine fund: a positive impact mezzanine fund for small and medium-sized companies, with a team specialized in impact transformation. This fund provides real quasi-equity (not counted in debt ratios) without opening the capital of companies, and supports them in their development and impact disruption while offering significant financial incentives.
As a business partner, GENEO mobilizes to provide support for the execution of structuring, growth and transformation projects thanks to its teams, but also its specialized "business partners" (external growth, positive impact, digital and innovation). It also has a platform of more than 140 independent experts and a community of nearly 200 families and entrepreneurs, offering a sharing of experiences and a business network unheard of in France. The
of this operational support are adapted to the specific needs of each company and formalized jointly by the GENEO team, the management team and the other shareholders of the company in a "Growth Book".
Passionate about those who make, create and want to move the lines, the only ambition of the GENEO team is to bring the ambition of each entrepreneur to the top.
At GENEOwhen we invest, we invest!
For more information: www.geneocapitalentrepreneur.com
https://twitter.com/GeneoCapital
https://www.linkedin.com/company/geneo-capital-entrepreneur
https://www.youtube.com/channel/UChZh_aqfqG-v9ANGWlLY2Tw
Press contact:
Verbatee Agency : Cyrille Lachèvre
06 20 42 12 08 - c.lachevre@verbatee.com
